Bioavailability of 5 mg of Levamlodipine Maleate Tablets Versus 10 mg of Amlodipine Besylate Tablet in Healthy Subjects
Randomized Open-label Single-Dose Two-Way Crossover Study to Assess the Relative Bioavailability of 5mg Levamlodipine Tablet vs. 10mg Amlodipine Besylate Tablet in Healthy Subjects Followed by a Phase to Study Food Effect on the PK of Levamlodipine
Sponsor: CSPC Ouyi Pharmaceutical Co., Ltd.
A PHASE1 clinical study on Hypertension, this trial is completed. The trial is conducted by CSPC Ouyi Pharmaceutical Co., Ltd. and has accumulated 7 data snapshots since 2018. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE1
-
Oct 2021 — Jul 2024 [monthly]
Completed PHASE1
-
Jan 2021 — Oct 2021 [monthly]
Completed PHASE1
-
May 2019 — Jan 2021 [monthly]
Completed PHASE1
▶ Show 2 earlier versions
-
Dec 2018 — May 2019 [monthly]
Completed PHASE1
Status: Recruiting → Completed
-
Oct 2018 — Dec 2018 [monthly]
Recruiting PHASE1
First recorded
May 2018
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- CSPC Ouyi Pharmaceutical Co., Ltd.
- Conjupro Biotherapeutics, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .